abstract |
The present invention provides a method for preventing or treating a T cell mediated inflammatory / autoimmune disease or disorder in a subject having glucocorticoid dysregulation, said method comprising a cyclooxygenase in a subject in need of such treatment. -2 administration of an inhibitor. The Cox-2 inhibitor may be a Cox-2 selective inhibitor. Compositions, pharmaceutical compositions and kits are provided for carrying out the invention. |